Medtronic Expands ENT Portfolio with the Acquisition of Ai Biomed and the Approval of NIM Vital Nerve Monitoring System

November 2, 2020 Auto Bot Acquires, M&A, receives, regulatory, US FDA’s Approval 0

Shots:

  • Medtronic has expanded its portfolio of technologies focusing on improving the safety of head and neck surgeries with the acquisition of Ai Biomed and the US FDA’s 510(k) clearance of NIM Vital nerve monitoring system
  • The NIM Vital nerve monitoring system enables physicians to identify, confirm, and monitor nerve function to help reduce the risk of nerve damage during head and neck surgery
  • The acquisition marks the 7th acquisition by Medtronic in 2020. The acquisition will add the PTeye laser system to Medtronic’s ENT portfolio which a tissue-detecting probe used in thyroid surgery

Click here to­ read the full press release/ article | Ref: Medtronic | Image: Market Watch

The post Medtronic Expands ENT Portfolio with the Acquisition of Ai Biomed and the Approval of NIM Vital Nerve Monitoring System first appeared on PharmaShots.